An old drug with a new future: bendamustine in multiple myeloma.
about
Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: results of a prospective phase 2 Spanish/PETHEMA trial.Clinical Outcomes Related to the Use of Bendamustine Therapy for Multiple Myeloma Patients Relapsed/Refractory to Immunomodulatory Drugs and Proteasome Inhibitors.Dose-intensified bendamustine followed by autologous peripheral blood stem cell support in relapsed and refractory multiple myeloma with impaired bone marrow function.
P2860
An old drug with a new future: bendamustine in multiple myeloma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
An old drug with a new future: bendamustine in multiple myeloma.
@en
type
label
An old drug with a new future: bendamustine in multiple myeloma.
@en
prefLabel
An old drug with a new future: bendamustine in multiple myeloma.
@en
P2093
P2860
P1476
An old drug with a new future: bendamustine in multiple myeloma
@en
P2093
Angela Palummo
Carla Mazzone
Ernesto Vigna
Eugenio Lucia
Fortunato Morabito
Laura De Stefano
Lucio Morabito
Massimo Gentile
Sabrina Bossio
Teresa Granata
P2860
P304
P356
10.1517/14656566.2013.837885
P407
P577
2013-09-21T00:00:00Z